Cancer Institute A national cancer institute
designated cancer center

Department: Stanford Cancer Institute

K

  • Assistant Professor of Radiology (General Radiology) at the Stanford University Medical Center
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Oncologic Imaging
    • Hepatobiliary and pancreatic imaging
    • Urogenital imaging
    Research Interest

    Novel ultrasound technologies
    Perfusion CT imaging of abdominal tumors

  • Professor of Otolaryngology - Head and Neck Surgery and, by courtesy, of Neurosurgery at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Head and Neck Cancer
    • Head and Neck Cancers
    • Head and Neck Cancers - Head and Neck Surgery
    Research Interest

    1) New therapeutic approaches for head and neck cancer, including immune stimulation possibilities (IRX-2 protocol), integration of biological modifiers, and, eventually, genetic approaches.
    2) Head and neck cancer stem cells: identification, characterization, control--in conjunction with the Irv Weissman and Michael Clarke labs in the Stem Cell Institute
    3) Development of innovative surgical methods at the anterior cranial base

  • Professor of Radiation Oncology, Emeritus
    Member, Stanford Cancer Institute
    Clinical Focus
    • Brain / Central Nervous System Tumors
    • Brain / Central Nervous System Tumors - Radiation Oncology
    • Breast Cancer
    Research Interest

    Gynecologic malignancies; Rectal/and cancer; Breast Cancer; Hodgkin's disease; Hyperthermia; intraoperative radiation therapy; High dose rate radiation therapy; Predictive assays; Patterns of tumor spread; Health care finance.

  • Professor of Neurosurgery and of Medicine (Endocrinology) at the Stanford University Medical Center, Lucile Salter Packard Children's Hospital and at PAVAHCS
    Member, Stanford Cancer Institute
    Clinical Focus
    • Neuro Oncology
    • Endocrine
    • Endocrine - Endocrinology
    Research Interest

    Dr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and CushingÂ’s syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education

  • Dennis Farrey Family Professor in Pediatrics, and Professor of Genetics
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Research Interest

    Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

  • Research Interest

    Dr. Keegan's research focuses on cancer epidemiology and cancer surveillance, with primary areas of interest in genetic and modifiable factors that influence the occurrence of and survival after cancer.

  • Carl J. Herzog Professor in Dermatology in the School of Medicine
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Clinical Focus
    • Cutaneous (Dermatologic) Oncology
    • Dermatology
    • General Dermatology
    Research Interest

    We work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.

  • Wells H. Rauser and Harold M. Petiprin Professor in the School of Engineering and Professor of Chemistry and, by courtesy, of Biochemistry
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Director, Stanford ChEM-H
    Member, Stanford Neurosciences Institute
    Research Interest

    Research interests in this laboratory lie at the interface of chemistry and medicine.

    For the past several years, we have investigated the catalytic mechanisms of modular megasynthases such as polyketide synthases, with the concomitant goal of harnessing their programmable chemistry for preparing new antibiotics. Recent accomplishments include methods for heterologous production of polyketides; genetically reprogrammed biosynthesis of anthraquinones and polypropionates; and chemo-biosynthesi

  • Assistant Professor of Radiation Oncology at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Gynecologic Cancer
    • Radiation Oncology
    • Radiation Oncology
  • Professor (Research) of Medicine (General Internal Medicine), Emeritus
    Member, Stanford Cancer Institute
    Research Interest

    My research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.

  • Assistant Professor of Pathology and of Dermatology at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Cutaneous (Dermatologic) Oncology
    • Cancer- cutaneous oncology
    • Melanocytic neoplasia
  • Professor of Developmental Biology and, by courtesy, of Medicine (Oncology)
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Research Interest

    We study the genetics of pancreatic islet cell differentiation using molecular, embryologic and genetic methods in several model systems, including mice, embryonic stem cells, and Drosophila. Our work suggests that critical factors required for islet development are also needed to maintain essential functions of the mature islet. Our knowledge of genetic and cellular pathways governing islet formation has allowed us to use stem cell lines to produce islet replacements in vitro.

  • The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Cutaneous (Dermatologic) Oncology
    • Cutaneous Lymphoma
    • Cutaneous Lymphoma - Dermatology
    Research Interest

    Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.

  • Professor of Health Research and Policy (Epidemiology) and of Medicine (Stanford Prevention Research Center)
    Member, Stanford Cancer Institute
    Affiliate, Stanford Woods Institute for the Environment
    Research Interest

    My interests include the application of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.

  • Associate Professor of Radiation Oncology
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • Cutaneous (Dermatologic) Oncology
    • Lymphoma
    • Radiation Oncology
    Research Interest

    Our interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.

  • Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Lymphoma
    • Oncology
    Research Interest

    My research is focused on developing novel therapeutic strategies to enhance anti-tumor immunity. Investigation of preclinical models of bone marrow transplantation and immunomodulatory antibody therapy provides the platform for translation to early phase clinical trials.

  • Professor of Radiation Oncology (Radiation Therapy)
    Member, Bio-X
    Member, Stanford Cancer Institute
    Clinical Focus
    • GI Oncology
    • Radiation Oncology
    • Pancreatic Cancer
    Research Interest

    The focus of my laboratory is to understand the role of hypoxia and the tumor microenvironment on malignant progression. My clinical area of interest is in the application of chemoradiotherapy and stereotactic body radiotherapy (SBRT) for GI malignancies.

  • Professor (Research) of Psychiatry and Behavioral Sciences
    Member, Stanford Cancer Institute
    Research Interest

    Dr. Koopman's research is focused in three primary areas:

    1) Investigating factors associated with neuropsychiatric and other symptoms and quality of life in persons with serious illness.

    2) Evaluating psychosocial and other kinds of interventions to improve health and quality of life among persons who are living with or are survivors of serious illness.

    3) Examining factors associated with health behaviors (e.g., sleep, sexuality, and substance abuse) among the medically ill.

  • Professor of Biostatistics in Psychiatry, Emerita
    Member, Stanford Cancer Institute
    Research Interest

    I am interested in the methodology pertinent to dealing with research problems where biological and behavioral interests meet. These interests have been applied not only in psychiatric research, but in those areas of Cardiology, Pediatrics and other fields of medicine in which behavioral research is becoming ever more salient.

  • Professor of Biochemistry
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Research Interest

    - Lung development and stem cells
    - Neural control of breathing
    - Lung diseases including lung cancer
    - New genetic model organisms for medicine

  • Shelagh Galligan Professor in the School of Medicine, Emeritus
    Member, Bio-X
    Member, Stanford Cancer Institute
    Research Interest

    Mechanisms and therapies for infection, cancer, autoimmunity and transplantation.

  • Clinical Focus
    • Fellow
  • Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • GI Oncology
    • Esophageal Cancer
    Research Interest

    I specialize in the treatment of gastrointestinal malignancies. My research involves clinical trials and epidemiologic studies, primarily in neuroendocrine and gastroesophageal cancers.

  • Professor of Medicine (Hematology) and, by courtesy, of Chemical and Systems Biology
    Member, Bio-X
    Member, Child Health Research Institute
    Member, Stanford Cancer Institute
    Faculty Fellow, Stanford ChEM-H
    Clinical Focus
    • Hematology
    • Medical Oncology
    Research Interest

    We study angiogenesis, cancer genomics, intestinal stem cells (ISC), and hepatic glucose metabolism. We use primary organoid cultures of diverse tissues for oncogene functional screening and therapeutics discovery. Angiogenesis projects include endothelial miRNA and GPCR ko mice, blood-brain barrier regulation, stroke therapeutics and anti-angiogenic cancer therapy. ISC projects apply organoid culture and ko mice to injury-inducible vs homeostatic stem cells and symmetric division mechanisms.

  • Assistant Professor of Medicine (Oncology) and of Health Research and Policy at the Stanford University Medical Center
    Member, Stanford Cancer Institute
    Clinical Focus
    • Breast Cancer
    • Cancer Genetics
    • Medical Oncology
    Research Interest

    Genetics, risk-reduction and outcomes of women's cancers

Stanford Medicine Resources:

Footer Links: